BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 20032081)

  • 21. Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells.
    Wu G; Luo J; Rana JS; Laham R; Sellke FW; Li J
    Cardiovasc Res; 2006 Feb; 69(2):512-9. PubMed ID: 16336951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
    Aljada A; O'Connor L; Fu YY; Mousa SA
    Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.
    Walther U; Emmrich K; Ramer R; Mittag N; Hinz B
    Oncotarget; 2016 Mar; 7(9):10345-62. PubMed ID: 26863638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. n-3 polyunsaturated fatty acids stimulate osteoclastogenesis through PPARγ-mediated enhancement of c-Fos expression, and suppress osteoclastogenesis through PPARγ-dependent inhibition of NFkB activation.
    Nakanishi A; Tsukamoto I
    J Nutr Biochem; 2015 Nov; 26(11):1317-27. PubMed ID: 26303404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective effects of PPARgamma agonists and antagonists on human pre-adipocyte differentiation.
    Leyvraz C; Suter M; Verdumo C; Calmes JM; Paroz A; Darimont C; Gaillard RC; Pralong FP; Giusti V
    Diabetes Obes Metab; 2010 Mar; 12(3):195-203. PubMed ID: 19895635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells.
    Terrasi M; Bazan V; Caruso S; Insalaco L; Amodeo V; Fanale D; Corsini LR; Contaldo C; Mercanti A; Fiorio E; Lo Re G; Cicero G; Surmacz E; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1368-74. PubMed ID: 23254958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol inhibits macrophage expression of EMMPRIN by activating PPARgamma.
    Ge H; Zhang JF; Guo BS; He Q; Wang BY; He B; Wang CQ
    Vascul Pharmacol; 2007 Feb; 46(2):114-21. PubMed ID: 17055343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
    Subbaramaiah K; Lin DT; Hart JC; Dannenberg AJ
    J Biol Chem; 2001 Apr; 276(15):12440-8. PubMed ID: 11278336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbon monoxide (from CORM-2) inhibits high glucose-induced ICAM-1 expression via AMP-activated protein kinase and PPAR-gamma activations in endothelial cells.
    Nizamutdinova IT; Kim YM; Kim HJ; Seo HG; Lee JH; Chang KC
    Atherosclerosis; 2009 Dec; 207(2):405-11. PubMed ID: 19524923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VEGF stimulates PKD-mediated CREB-dependent orphan nuclear receptor Nurr1 expression: role in VEGF-induced angiogenesis.
    Zhao D; Desai S; Zeng H
    Int J Cancer; 2011 Jun; 128(11):2602-12. PubMed ID: 20715116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PPARδ ligand L-165041 inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related to PPARδ.
    Park JH; Lee KS; Lim HJ; Kim H; Kwak HJ; Park HY
    J Cell Biochem; 2012 Jun; 113(6):1947-54. PubMed ID: 22234939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen/deuterium-exchange (H/D-Ex) of PPARgamma LBD in the presence of various modulators.
    Hamuro Y; Coales SJ; Morrow JA; Molnar KS; Tuske SJ; Southern MR; Griffin PR
    Protein Sci; 2006 Aug; 15(8):1883-92. PubMed ID: 16823031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells.
    Michaelis UR; Falck JR; Schmidt R; Busse R; Fleming I
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):321-6. PubMed ID: 15569819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells.
    Whiteside C; Wang H; Xia L; Munk S; Goldberg HJ; Fantus IG
    Exp Diabetes Res; 2009; 2009():910783. PubMed ID: 19609456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
    Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
    Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression.
    Selva DM; Hammond GL
    Endocrinology; 2009 May; 150(5):2183-9. PubMed ID: 19179433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.